Key result
The hyperfunction or dysfunction of chloride channels, including TMEM16A, TMEM16B, ClC-3, and ClC-7, is associated with the pathogenesis of cirrhotic portal hypertension, pulmonary arterial hypertension, cerebral ischemia, and osteoarthritis.
Why the study?
The physiological and pathological roles of Cl- channels have not been examined as extensively as cation channels, despite their role in regulating biological homeostasis and disease mechanisms.
Chloride channels, particularly TMEM16A and ClC-3, regulate vascular smooth muscle and endothelial cell functions and represent potential novel therapeutic targets for pulmonary arterial hypertension and other vascular diseases.
Hypothesis-generating for TMEM16A/ClC-3 modulation in vascular diseases; leaves open clinical translation pending prospective trials.
Cl− influx and efflux through Cl− channels play a role in regulating the homeostasis of biological functions. Therefore, the hyperfunction or dysfunction of Cl− channels elicits pathological mechanisms. The Cl− channel superfamily includes voltage-gated Cl− (ClC) channels, Ca2+-activated Cl− channels (ClCa; TMEM16A/TMEM16B), cystic fibrosis transmembrane conductance regulator channels, and ligand-gated Cl− channels. These channels are ubiquitously expressed to regulate ion homeostasis, muscle tonus, membrane excitability, cell volume, survival, neurotransmission, and transepithelial transport. The activation or inhibition of Cl− channels changes the membrane potential, thereby affecting cytosolic Ca2+ signals. An elevation in cytosolic [Ca2+] triggers physiological and pathological responses in most cells. However, the roles of Cl− channels have not yet been examined as extensively as cation (Na+, Ca2+, and K+) channels. We recently reported the functional expression of: (i) TMEM16A/ClCa channels in portal vein and pulmonary arterial smooth muscle cells (PASMC), pinealocytes, and brain capillary endothelial cells; (ii) TMEM16B/ClCa channels in pinealocytes; (iii) ClC-3 channels in PASMC and chondrocytes; and (iv) ClC-7 channels in chondrocytes. We also showed that the down-regulation of TMEM16A and ClC-7 channel expression was associated with cirrhotic portal hypertension and osteoarthritis, respectively, whereas the enhanced expression of TMEM16A and ClC-3 channels was involved in the pathogenesis of cerebral ischemia and pulmonary arterial hypertension, respectively. Further investigations on the physiological/pathological functions of Cl− channels will provide insights into biological functions and contribute to the screening of novel target(s) of drug discovery for associated diseases.
No takes yet. Share an insight, caveat, or question.
Hisao Yamamura (2023) conducted a review in Chloride channel-related pathologies. Chloride channels (TMEM16A, TMEM16B, ClC-3, ClC-7) was evaluated. The hyperfunction or dysfunction of chloride channels, including TMEM16A, TMEM16B, ClC-3, and ClC-7, is associated with the pathogenesis of cirrhotic portal hypertension, pulmonary arterial hypertension, cerebral ischemia, and osteoarthritis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: